Cargando…
Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum]
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Dove
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326273/ https://www.ncbi.nlm.nih.gov/pubmed/34349509 http://dx.doi.org/10.2147/IJN.S330286 |
| _version_ | 1783731753734635520 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8326273 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83262732021-08-03 Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum] Int J Nanomedicine Corrigendum Dove 2021-07-27 /pmc/articles/PMC8326273/ /pubmed/34349509 http://dx.doi.org/10.2147/IJN.S330286 Text en © 2021 Edis et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Corrigendum Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum] |
| title | Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum] |
| title_full | Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum] |
| title_fullStr | Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum] |
| title_full_unstemmed | Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum] |
| title_short | Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum] |
| title_sort | nanocarriers-mediated drug delivery systems for anticancer agents: an overview and perspectives [corrigendum] |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326273/ https://www.ncbi.nlm.nih.gov/pubmed/34349509 http://dx.doi.org/10.2147/IJN.S330286 |